Marta Medeot

Marta Medeot

UNVERIFIED PROFILE

Are you Marta Medeot?   Register this Author

Register author
Marta Medeot

Marta Medeot

Publications by authors named "Marta Medeot"

Are you Marta Medeot?   Register this Author

18Publications

575Reads

25Profile Views

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial.

Lancet Haematol 2019 Oct 9. Epub 2019 Oct 9.

Department of Haematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland; Faculty of Medicine, University of Rzeszow, Rzeszow, Poland.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23523026193015
Publisher Site
http://dx.doi.org/10.1016/S2352-3026(19)30157-7DOI Listing
October 2019

How could patient reported outcomes improve patient management in chronic myeloid leukemia?

Expert Rev Hematol 2017 Jan 30;10(1):9-14. Epub 2016 Nov 30.

a Division of Hematology and BMT, Department of Experimental and Clinical Medical Sciences , Azienda Sanitaria Universitaria Integrata di Udine , Udine , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2017.1262758DOI Listing
January 2017

Long-term efficacy and safety of nilotinib therapy after imatinib failure in eosinophilic myeloproliferative neoplasm and ETV6-ABL rearrangement.

Ann Hematol 2015 Aug 23;94(8):1423-4. Epub 2015 Apr 23.

Division of Hematology and Bone Marrow Transplantation, Azienda Ospedaliero-Universitaria di Udine, Udine, Italy,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00277-015-2381-4
Publisher Site
http://dx.doi.org/10.1007/s00277-015-2381-4DOI Listing
August 2015

Clinical factors predictive of myelofibrotic evolution in patients with polycythemia vera.

Ann Hematol 2015 May 20;94(5):873-4. Epub 2014 Nov 20.

Division of Hematology and BMT, Department of Experimental and Clinical Medical Sciences, Azienda Ospedialiero-Universitaria di Udine, P.le S. M. Misericordia, 15-33100, Udine, Italy,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-014-2257-zDOI Listing
May 2015

Long lasting remission after haploidentical stem cell transplant and pre-emptive donor lymphocyte infusions in a patient with primary refractory Hodgkin lymphoma.

Leuk Lymphoma 2015 Apr 13;56(4):1129-31. Epub 2014 Aug 13.

Department of Hematology, Stem Cell Transplant Unit, DISM, University Hospital , Udine , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.946024DOI Listing
April 2015

Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning.

J Clin Oncol 2014 Nov 29;32(31):3497-505. Epub 2014 Sep 29.

Christopher G. Kanakry, Marta Medeot, Richard J. Jones, Leo Luznik, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD; Paul V. O'Donnell, Terry Furlong, Marco Mielcarek, Fred Hutchinson Cancer Research Center, Seattle, WA; Marcos J. de Lima, Wei Wei, Richard E. Champlin, Peter F. Thall, Borje S. Andersson, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2013.54.0625
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.54.0625DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209101PMC
November 2014

Factors affecting outcome of allogeneic stem cell transplantation as salvage in patients with acute myeloid leukemia primary refractory to intensive induction therapy.

Am J Hematol 2014 Sep 19;89(9):933-4. Epub 2014 Jun 19.

Division of Hematology and Bone Marrow Transplantation, Department of Clinical and Experimental Medical Sciences, AOU Udine, Udine, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.23769
Publisher Site
http://dx.doi.org/10.1002/ajh.23769DOI Listing
September 2014

Cardiotoxicity of imatinib: At the heart of the problem.

Leuk Res 2011 Jan;35(1):36-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2010.09.021DOI Listing
January 2011

Low-dose rituximab in adult patients with primary immune thrombocytopenia.

Eur J Haematol 2010 Oct 28;85(4):329-34. Epub 2010 Jul 28.

Clinica Ematologica, DIRM, Azienda Ospedaliero Universitaria S. Maria Misericordia, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2010.01486.xDOI Listing
October 2010